In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer

Author： Wang Hua   Xu Hui   Lu Wei   Zhu Lin   Yu Yun   Hong Fan  

Publisher： Springer Publishing Company

ISSN： 0932-0067

Source： Archives of Gynecology and Obstetrics, Vol.289, Iss.1, 2014-01, pp. : 155-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dual detection of human herpesvirus-6 and human papillomavirus type 16 and 18 in cervical carcinoma

By Yadav M   Padmanathan A   Arivananthan M  

Journal of Obstetrics & Gynaecology, Vol. 17, Iss. 1, 1997-01 ,pp. : 86-87

Informa Healthcare

Access to resources Recommend Favorite

Seric and local antibodies against a synthetic peptide of HPV16

By Dreyfus M.   Baldauf J.-J.   Ritter J.   Obert G.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 59, Iss. 2, 1995-04 ,pp. : 187-191

Elsevier

Access to resources Recommend Favorite

Human papillomavirus and control of cervical cancer in India

By Bharti Alok C   Shukla Shirish   Mahata Sutapa   Hedau Suresh   Das Bhudev C  

Expert Review of Obstretrics and Gynecology, Vol. 5, Iss. 3, 2010-05 ,pp. : 329-346

Informa Healthcare

Access to resources Recommend Favorite

Human papillomavirus and cervical cancer: where are we now?

By Kirwan J.M.J.   Herrington C.S.  

British Journal of Obstetrics and Gynaecology, Vol. 108, Iss. 12, 2001-12 ,pp. : 1204-1213

Elsevier

Access to resources Recommend Favorite

Cervical response to vaccination against HPV16 E7 in case of severe dysplasia

By Simon P.   Buxant F.   Hallez S.   Burny A.   Fayt I.   Anaf V.   Noel J.C.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 109, Iss. 2, 2003-08 ,pp. : 219-223

Elsevier

Access to resources Recommend Favorite